Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals is a clinical-stage pharmaceutical company based in New York, focused on developing and bringing lifesaving treatments to people affected by acute central nervous system (CNS) injuries and diseases. The company is advancing the development of CIRARA, a drug for severe stroke conditions such as large hemispheric infarction, with a strong pipeline of clinical trials and patents. Their mission is to improve outcomes for patients with devastating CNS injuries.
Industries
Nr. of Employees
small (1-50)
Remedy Pharmaceuticals, Inc.
New York, New York, United States, North America
Products
Intravenous glyburide formulation (clinical-stage therapeutic candidate)
A proprietary intravenous formulation of glyburide developed for treatment of large-territory acute ischemic stroke to reduce malignant cerebral edema and improve functional outcomes; evaluated in Phase 2 and Phase 3 randomized clinical trials.
Intravenous glyburide formulation (clinical-stage therapeutic candidate)
A proprietary intravenous formulation of glyburide developed for treatment of large-territory acute ischemic stroke to reduce malignant cerebral edema and improve functional outcomes; evaluated in Phase 2 and Phase 3 randomized clinical trials.
Services
Clinical-stage drug development for acute CNS injuries
End-to-end clinical development activities for investigational therapies targeting acute central nervous system injuries, including trial design, execution, regulatory engagement, and data dissemination.
Clinical-stage drug development for acute CNS injuries
End-to-end clinical development activities for investigational therapies targeting acute central nervous system injuries, including trial design, execution, regulatory engagement, and data dissemination.
Expertise Areas
- Clinical trial management
- Acute stroke therapeutics development
- Neurocritical care clinical research
- Regulatory strategy and FDA interactions for CNS drugs
Key Technologies
- CT perfusion (CTP) imaging
- MRI diffusion-weighted imaging
- ASPECTS scoring
- NIH Stroke Scale (NIHSS)